About Oncology Specialties, PC; Clearview Cancer Institute
"Clearview Cancer Institute is north Alabamas leading cancer treatment center. For over 30 years we've provided leading-edge treatment & compassion."
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Celgene
5
BeiGene
1
Biodesix, Inc.
1
EGEN, Inc.
1
EMD Serono Research & Development Institute, Inc.
1
Jazz Pharmaceuticals
1
Morphotek
1
Pharmacyclics LLC.
1
Regeneron Pharmaceuticals
1
Clinical Trials at Oncology Specialties, PC; Clearview Cancer Institute
During the past decade, Oncology Specialties, PC; Clearview Cancer Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer
Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)
2015-05-01
2019-04-25
Completed
430
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Oncology Specialties, PC; Clearview Cancer Institute" #1 sponsor was "Celgene" with 5 trials, followed by "BeiGene" with 1 trials
sponsored, "Biodesix, Inc." with 1 trials sponsored, "EGEN, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc."
with 1 trials sponsored. Other sponsors include -1 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Specialties, PC; Clearview Cancer Institute"
#1 collaborator was "Eisai Europe Ltd. (United Kingdom)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "The Leukemia and Lymphoma Society" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Oncology Specialties, PC; Clearview Cancer Institute
According to Clinical.Site data, the most researched conditions in "Oncology Specialties, PC; Clearview Cancer Institute" are
"Waldenstrom Macroglobulinemia" (2 trials), "B Cell Non-Hodgkin's Lymphoma" (1 trials), "Basal Cell Carcinoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma" (1 trials). Many other conditions were trialed in "Oncology Specialties, PC; Clearview Cancer Institute" in a lesser frequency.
Clinical Trials Intervention Types at Oncology Specialties, PC; Clearview Cancer Institute
Most popular intervention types in "Oncology Specialties, PC; Clearview Cancer Institute" are "Drug" (10 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "AVL-292" (1 trials), "Abraxane (Induction)" (1 trials), "Abraxane (Maintenance)" (1 trials) and "Albumin-bound paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Oncology Specialties, PC; Clearview Cancer Institute
The vast majority of trials in "Oncology Specialties, PC; Clearview Cancer Institute" are
11 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Oncology Specialties, PC; Clearview Cancer Institute
Currently, there are NaN active trials in "Oncology Specialties, PC; Clearview Cancer Institute".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Oncology Specialties, PC; Clearview Cancer Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Specialties, PC; Clearview Cancer Institute, 3 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Oncology Specialties, PC; Clearview Cancer Institute
Oncology Specialties, PC; Clearview Cancer Institute has several departments that took part in Clinical trials: "Clearview Cancer Institute" - 103 trials